{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:49:24Z","timestamp":1790286564950,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017642","name":"Spanish National Plan for Scientific and Technical Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003091","name":"Government of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017642","name":"Spanish National Plan for Scientific and Technical Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017642","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bmc.2020.115927","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T18:20:24Z","timestamp":1607624424000},"page":"115927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Novel indolylarylsulfone derivatives as covalent HIV-1 reverse transcriptase inhibitors specifically targeting the drug-resistant mutant Y181C"],"prefix":"10.1016","volume":"30","author":[{"given":"Ping","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estrella","family":"Frutos-Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Men\u00e9ndez-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2020.115927_b0005","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acs.jmedchem.5b00497","article-title":"Anti-HIV drug discovery and development: current innovations and future trends","volume":"59","author":"Zhan","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115927_b0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrd.2016.69","article-title":"The HIV therapy market","volume":"15","author":"Gubernick","year":"2016","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.bmc.2020.115927_b0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2013.01.007","article-title":"Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments","volume":"98","author":"Men\u00e9ndez-Arias","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2020.115927_b0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/v8100263","article-title":"Mechanistic study of common non-nucleoside reverse transcriptase inhibitor-resistant mutations with K103N and Y181C substitutions","volume":"8","author":"Lai","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2020.115927_b0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2009.09.008","article-title":"Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989\u20132009)","volume":"85","author":"de Bethune","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2020.115927_b0030","doi-asserted-by":"crossref","first-page":"e1001810","DOI":"10.1371\/journal.pmed.1001810","article-title":"Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis","volume":"12","author":"Rhee","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.bmc.2020.115927_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158560","article-title":"Surveillance of HIV transmitted drug resistance in Latin America and the Caribbean: a systematic review and meta-analysis","volume":"11","author":"Avila-Rios","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2020.115927_b0040","doi-asserted-by":"crossref","first-page":"9725","DOI":"10.1073\/pnas.1711463114","article-title":"Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography","volume":"114","author":"Chan","year":"2017","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2020.115927_b0045","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1021\/jm00061a022","article-title":"5-Chloro-3-(phenylsulfonyl)indole-2-carboxamide: a novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase","volume":"36","author":"Williams","year":"1993","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115927_b0050","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1021\/jm0211063","article-title":"Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies","volume":"46","author":"Silvestri","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115927_b0055","doi-asserted-by":"crossref","DOI":"10.1177\/2040206617753443","article-title":"Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors","volume":"26","author":"Famiglini","year":"2018","journal-title":"Antiviral Chem Chemotherapy"},{"key":"10.1016\/j.bmc.2020.115927_b0060","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bmcl.2007.11.085","article-title":"Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)","volume":"18","author":"Zhao","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115927_b0065","article-title":"Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing","volume":"15","author":"Zhao","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115927_b0070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejmech.2016.10.009","article-title":"Discovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-guided scaffold morphing and fragment rearrangement","volume":"27","author":"Li","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115927_b0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0166-0934(88)90134-6","article-title":"Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds","volume":"20","author":"Pauwels","year":"1988","journal-title":"J Virol Methods"},{"key":"10.1016\/j.bmc.2020.115927_b0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nprot.2007.517","article-title":"Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later","volume":"3","author":"Pannecouque","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bmc.2020.115927_b0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/abio.2001.5045","article-title":"An integrated system to study multiply substituted human immunodeficiency virus type 1 reverse transcriptase","volume":"292","author":"Boretto","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmc.2020.115927_b0090","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jmb.2005.04.004","article-title":"Suppression of multidrug-resistant HIV-1 reverse transcriptase primer unblocking activity by alpha-phosphate-modified thymidine analogues","volume":"349","author":"Matamoros","year":"2005","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2020.115927_b0095","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1093\/nar\/gkv077","article-title":"Effects of HIV-1 reverse transcriptase connection subdomain mutations on polypurine tract removal and initiation of (+)-strand DNA synthesis","volume":"43","author":"Betancor","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2020.115927_b0100","unstructured":"Sybyl-X Molecular Modeling Software Packages, Version 2.0. TRIPOS Associates, Inc; St. Louis, MO, USA; 2012."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620307574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620307574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:11:30Z","timestamp":1760836290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089620307574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":20,"alternative-id":["S0968089620307574"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115927","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel indolylarylsulfone derivatives as covalent HIV-1 reverse transcriptase inhibitors specifically targeting the drug-resistant mutant Y181C","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115927"}}